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Abstract
Background: Radiofrequency (RF) linear ablation at the left atrial (LA) roof and bottom to isolate the 
LA posterior wall using contiguous and optimized RF lesions was evaluated. Achieving isolation of the 
LA posterior wall is challenging as two continuous linear lesion sets are necessary.
Methods: Forty consecutive patients with symptomatic atrial fibrillation (AF) and arrhythmia sub-
strates affecting the LA posterior wall underwent posterior wall isolation by linear lesions across the 
roof and bottom. The cohort was divided into two groups: group 1 (20 patients) linear ablation guided 
by contact force (CF) only; group 2 (20 patients) guided by ablation index (AI) and interlesion distance.
Results: Bidirectional block across the LA roof and bottom was achieved in 40/40 patients. Additional 
endocardial RF applications in 5 patients from group 1 vs. 3 patients from group 2 resulted in pos-
terior wall isolation in all patients. Procedure duration was almost equal in both groups. CF and AI 
were significantly higher in group 2 for the roof line, whereas no statistical difference was found for the 
bottom line. AI-guided LA posterior wall isolation led to a significantly lower maximum temperature 
increase. The mean AI value as well as the mean value for catheter-to-tissue CF for the roof line were 
significantly higher when AI-guided ablation was performed. Standard deviation in group 2 showed  
a remarkably lower dispersion.
Conclusions: Ablation index guided posterior wall isolation for substrate modification is safe and 
effective. AI guided application of the posterior box lesion allows improved lesion formation. (Cardiol J)
Key words: atrial fibrillation, catheter ablation, posterior wall isolation, ablation index, 
contact force
Introduction
Catheter ablation for persistent atrial fibrilla-
tion (PERS) is challenging and is associated with 
only a moderate outcome [1–4]. The mechanisms 
initiating and perpetuating atrial fibrillation (AF) 
are still not completely understood and therefore, 
ablation strategies are heterogeneous [1, 2, 5]. 
Several observations have led to individual mecha-
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associated cardiac remodeling which emphasizes 
the need for personalized paths in AF management. 
The posterior left atrial (LA) wall has a common 
embryological origin with the pulmonary veins 
(PVs) and therefore a comparable arrhythmogenic 
potential, especially when there is evidence of 
myocardial fibrosis [3, 6, 7]. A beneficial effect of 
the LA posterior wall isolation (PWI) has been 
demonstrated among patients who underwent sur-
gical AF therapy [8], whereas conflicting outcome 
data exist regarding the value of LA PWI adjunctive 
to or beyond PV isolation (PVI) performing endo-
cardial ablation [9–12]. However, there is sparse 
data reporting the feasibility, safety and efficacy 
of LA PWI as performing linear ablation in the LA 
remains challenging. Bidirectional block across LA 
lines should be the ablation endpoint [13], but this 
is only achieved in a limited number of patients [14] 
and incomplete electrical block can contribute to 
the development of an iatrogenic arrhythmia sub-
strate [15]. One of the most relevant drawbacks in 
performing posterior wall substrate modification 
is the risk of collateral damage to the esophagus 
[16]. Consequently, the theoretical advantages of 
PWI have to be balanced against the undisputed 
risk of major complications or incomplete electri-
cal block across the applied lines resulting in pro-
arrhythmic effects and arrhythmia recurrence [6]. 
Recently, new studies have reported an ablation 
approach in performing anatomical point-by-point 
radiofrequency (RF) ablation based on an indirect 
evaluation of lesion depth and delivery of contigu-
ous RF lesions [17, 18]. Focusing on PVI, it has 
been shown that acute and late PV reconnection 
resulted from an insufficient ablation index (AI) 
and/or from interlesion distance being too far [17]. 
This has also been reported from catheter ablation 
procedures performing linear lesion sets across the 
LA roof, anterior wall and mitral isthmus [19, 20]. 
However, these criteria on minimal AI and maximal 
interlesion distance have not yet been evaluated 
and not been validated for substrate modification at 
the LA posterior wall. Thus, the aim of this study 
was to evaluate feasibility and efficacy of AI-guided 
isolation of the posterior wall in patients suffering 
from PERS.
Methods
A total of 40 consecutive patients with drug-
-refractory PERS and a relevant amount of bipolar 
low-voltage affecting the LA posterior wall were 
included in this prospective observational analysis. 
AF was defined as persistent if episodes lasted 
> 7 days or required electrical or pharmacological 
cardioversion after ≥ 48 h from onset [13]. The 
mean AF duration before the procedure was as-
sessed by comprehensive review of the patients’ 
records including 12-lead-electrocardiograms and 
doctors’ letters. In this study AI was assessed and 
evaluated exclusively for PWI by means of linear 
lesion sets across the LA roof and bottom beyond 
proof or successful PVI. All patients were ablated 
at our institution. Written informed consent was 
obtained from each patient and the current study 
complies with the Declaration of Helsinki and was 
approved by the institutional review board. LA 
thrombus formation was ruled out prior to ablation 
in all patients. All procedures were performed on 
uninterrupted oral vitamin K anticoagulants with 
a target international normalized ratio of 2.0–3.0 on 
the day of the procedure, direct oral anticoagulants 
were discontinued the day of the procedure and 
resumed the same day after ruling out pericardial 
effusion. Catheter ablation was performed under 
deep sedation with bolus of midazolam and fentanyl 
and a continuous infusion of propofol. In all patients, 
preprocedural magnetic resonance imaging was 
performed to guide the intervention and to visualize 
the anatomical location and course of the esopha-
gus. A 6 F diagnostic catheter was inserted distal 
into the coronary sinus (CS) via the right femoral 
vein. Double transseptal puncture using 8.5 F SL1 
sheaths (SJM, St. Paul, Minnesota, USA) and a modi-
fied Brockenbrough technique was performed as 
previously described in detail [21]. Unfractionated 
heparin was administered according to the patient’s 
weight to maintain an activated clotting time ≥ 300 s.
Map acquisition
After transseptal puncture, a multipolar map-
ping catheter (Lasso or PentaRay, Biosense-Web-
ster Inc., Diamond Bar, CA, USA) and an open-tip 
irrigated RF catheter (8 Fr) with tip-integrated 
contact force (CF) sensor (Thermocool Smart-
Touch SF, Biosense-Webster Inc.) were positioned 
in the LA. Subsequent calibration of CF catheter, 
respiratory gating, and three-dimensional geom-
etry of the LA (Carto System®, Biosense Webster 
Inc.) were performed using ultra high-density 
mapping aiming for > 1000 mapping points for the 
estimation of bipolar LA voltage (Fig. 1). Bipolar 
voltage maps were created during sinus rhythm. 
In patients with PERS, sinus rhythm was restored 
by transthoracic direct electrical cardioversion at 
the beginning of the procedure. For the LA voltage 
map, the bipolar voltage reference interval was set 
between 0.05 and 0.5 mV. The definition of low-
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-voltage areas included one of the two following 
criteria: (1) absence of voltage or a bipolar voltage 
amplitude ≤ 0.05 mV, indistinguishable from noise; 
(2) low-voltage “abnormal” areas were defined 
with an amplitude ≤ 0.5 mV, as previously reported 
[22]. The total individual amount of LA bipolar low 
voltage was measured using the area measure-
ment tool. Patients with PERS undergoing a first 
catheter ablation procedure underwent PVI first. In 
patients undergoing a repeated ablation procedure, 
electrical isolation of the PVs was checked with 
the Lasso or PentaRay catheter and electrical rei-
solation of the PVs was performed if reconnection 
had occurred. Afterwards LA linear ablation at the 
roof and the bottom was subsequently performed 
to achieve posterior wall isolation if low-voltage 
areas were detected.
Ablation procedure
Catheter ablation was performed with an open-
irrigated tip catheter (Thermocool SmartTouch SF, 
Biosense Webster Inc.). After reconstruction of the 
LA, each PV ostium was identified by selective PV 
angiography and ablation was performed. Following 
PV ablation, PWI started with a linear lesion set 
across the LA roof from the superior aspect of the 
left PVs to the superior aspect of the right-sided 
PVs (Fig. 2). Irrigated RF was delivered, targeting 
a maximum temperature of 43°C, a maximum power 
level of 35 W and an infusion rate of 20 mL/min. 
The bottom line was drawn from the most inferior 
aspect of the left-sided PVs to the inferior aspect of 
the right PVs aiming for coverage the complete area 
of bipolar low-voltage within posterior wall (Fig. 2). 
The bottom line was applied with a maximum 
power limited to 30 W. Patients were divided into 
two groups according to the ablation protocol. In 
patients of group 1 (n = 20), lesion creation was 
guided by contact force targeting 10–40 g, aiming 
for local signal attenuation of ≥ 80% at each point 
[23, 24]. These procedures were used to calculate 
an individual AI for posterior wall isolation. How-
ever, the performing physician was blinded to all 
AI values. In patients of group 2 (n = 20), all pro-
Figure 1. Typical examples for areas with left atrial bipolar low voltage using ultra-high density mapping; A. Native 
bipolar low-voltage suggestive for fibrosis, B. Bipolar low voltage at the posterior wall after previous radiofrequency-
-guided pulmonary vein isolation (PVI); C. Diffuse distribution of native bipolar low voltage; D. Localization of bipolar 
low voltage following previous cryoballoon-guided PVI; posterior-anterior view; bipolar voltage reference interval 
was set as < 0.5 mV; LAA — left atrial appendage; LPVs — left-sided pulmonary vein; RPVs — right-sided pulmonary 
veins.
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cedures were guided by AI target values (AI roof 
line: 550; AI bottom line: 400), and targeting an 
interlesion distance ≤ 6 mm (Fig. 2). Conduction 
block along the lines was validated in sinus rhythm 
by widely spread double potentials along the whole 
lines, pacing manoeuvres (including entrance- and 
exit-block) and repeated voltage mapping,including 
area measurement, of the isolated posterior box 
(Fig. 2D). Procedural success was subsequently 
reconfirmed after a minimum waiting period of 
30 min. All patients were followed-up in the out-
patient clinic 3, 6 and 12 months after ablation. 
At each visit they were asked for any symptoms 
suggestive for arrhythmia recurrence or discom-
fort during respiration. Moreover, a 72 h-Holter 
electrocardiogram was routinely performed in all 
patients to monitor arrhythmia recurrence and AF 
burden. Following a 3-month blanking period, re-
currence was defined as any symptomatic episode 
of atrial tachycardia/AF lasting > 30 s.
Statistical methods
Continuous variables are reported as means 
± standard deviation and were compared with the 
Student t test for unpaired groups as required, and 
dichotomic variables as percentage and compared 
with c2 test of the Fisher test as required. A p value 
< 0.05 was considered as statistically significant.
Results
Patients’ characteristics
Forty consecutive patients (65% male), mean 
age 64 ± 9 years, that were routinely referred 
Figure 2. Patient specific example for ablation index (AI)-guided posterior wall isolation; A. After reconstruction of the 
left atrial (LA), each pulmonary vein (PV) ostium was identified; B. Pulmonary vein isolation was performed using AI; 
C. Posterior wall (PW) isolation started with a linear lesion set across the LA roof from the superior aspect of the left 
PVs (LPVs) to the superior aspect of the right-sided PVs (RPVs). The inferior line was drawn from the most inferior 
aspects of the left-sided PVs to the inferior aspects of the right PVs aiming for coverage of the complete area of bipolar 
low-voltage within PW isolation; D. Repeat voltage mapping to confirm isolation of the posterior box; LAA — left 
atrial appendage.
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to our hospital for LA ablation procedures due 
to PERS. Mean left ventricular ejection fraction 
was 53 ± 5% and LA diameter was 45 ± 7 mm. 
A significant low-voltage area at the posterior LA 
wall was detected in all patients. The groups did 
not differ significantly in terms of age, sex and 
cardiovascular risk factors. Baseline characteristics 
are reported in Table 1. 
Procedural data and success
For this study, analysis of the procedural data 
of all patients included a total of 601 RF applica-
tions. The whole procedure duration was compa-
rable between both groups with 98 ± 23 min in 
group 1 and 92 ± 9 min in group 2, respectively 
(p = 0.10). This was also the fact for the mean 
fluoroscopy time (group 1: 4.2 ± 1.6 min; group 2: 
4.1 ± 1.9 min; p = 0.87). Although there was no 
significant difference in terms of procedural dura-
tion, a remarkably lower variation in the AI-guided 
ablations was observed.
Acute isolation of the posterior wall was 
achieved in all cases. Bidirectional block of the 
roof line required a total of 5 ± 3 RF applications 
in group 1 and 4 ± 1 RF applications in group 2 
(p = 0.44). For the bottom line, a mean of 10 ± 7 
RF applications was required in group 1 and 10 ± 5 
RF applications in the AI-guided group (p = 0.84). 
There was no significant difference focussing on 
ablation duration for bidirectional block across 
the roof (1.9 ± 1.1 min group 1 vs. 1.5 ± 0.8 min 
group 2; p = 0.14) or the bottom line (3.5 ± 3.1 
min group 1 vs. 3.5 ± 1.6 min group 2; p = 0.95). 
First-pass block of the roof line was achieved in 
the majority of patients (n = 17 in CF-group and 
n = 18 in AI group). First-pass block of the bot-
tom line, resulting in LA posterior wall isolation 
was observed in 15/20 patients in group 1 (75%) 
and 17/20 patients in group 2 (85%; p = 0.43). No 
electrical reconduction of the posterior wall was 
found after the waiting period of 30 min in patients 
who underwent AI-guided posterior box isolation. 
In contrast, reconduction requiring reablation was 
observed in 3 (15%) patients from group 1. Gaps 
in the ablation lines were identified from signal 
mapping and pacing maneuvers in all cases. RF 
applications inside the box were not necessary. 
Of note, AI-guided LA PWI led to significantly 
lower maximum temperature rises measured at 
the catheter tip (roof line: 27 ± 1.4°C group 1 vs. 
25 ± 1.7°C group 2; p < 0.01; bottom line: 27 ± 1.2 
group 1 vs. 25 ± 1.7°C group 2; p < 0.01). Fur-
thermore, the mean AI value (roof line: 482 ± 108 
group 1 vs. 549 ± 74 group 2; p < 0.01; bottom line: 
Table 1. Baseline characteristics of all patients and their respective p-values.
Group 1 (CF) Group 2 (AI) P
Age [years] 63 ± 8 64 ± 17 0.37
Male 10 (50%) 16 (80%) 0.09
Left ventricular ejection fraction [%] 52 ± 13 53 ± 4 0.37
Left atrial diameter [mm] 44.3 ± 0.7 45 ± 1.9 0.22
Mean AF-duration prior ablation [months] 7 ± 2 8 ± 3 0.14
Amount of bipolar low voltage of the PW [%] 18 ± 12 20 ± 10 0.46
Ejection fraction [%] 53.8 ± 0.6 54.0 ± 0.7 0.83
Arterial hypertension 13 (65%) 15 (76%) 0.73
Congestive heart failure 2 (10%) 2 (10%) 1.0
Diabetes mellitus 2 (10%) 3 (15%) 1.0
Coronary artery disease 5 (25% 4 (20%) 1.0
CHA2DS2VASC Score 1.3±1.1 1.±1.2 0.16
Previous AAD 12 (60%) 14 (70%) 0.74
Beta-blockers 16 (80%) 17 (85%) 1.0
Previous ablations: 
Pulmonary vein isolation 9 (45%) 12 (60%) 0.53
LAMRT 1 (5%) 0 1.0
Cavotricuspid isthmus 3 (15%) 6 (30%) 0.45
AAD — antiarrhythmic drugs; AF — atrial fibrillation; LAMRT — left atrial macro-reentrant tachycardia; PW — posterior wall
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442 ± 127 group 1 vs. 428 ± 99 group 2; p < 0.01) 
as well as the mean value for catheter-to-tissue 
contact force for the roof line (32 ± 18 group 1 vs. 
39 ± 17 group 2; p = 0.01) were significantly higher 
when performing AI-guided catheter ablation. 
Besides these statistically significant differences 
mentioned above, the data highlighted even more 
the important benefit of using AI-guided posterior 
wall isolation in terms of safety and reproducible 
efficacy, as the AI variance creating each ablation 
lesion was remarkably low (Fig. 3). All procedural 
parameters are summarized in Table 2. No relevant 
complications were recorded during or after the 
intervention.
During a mean follow-up period of 12.1 ± 1.8 
months, 16/20 (80%) and 18/20 (90%) patients were 
free of any arrhythmia recurrence in both group 1 
and group 2, respectively. Focusing on arrhythmia 
recurrence, 2/4 patients from group 1 presented 
with LA macro-reentrant tachycardia (LAMRT), 
one patient presented with AF and LAMRT and 
another patient with AF. In contrast, 2 patients with 
AF recurrence were observed in group 2.
Discussion
Main findings
This is the first study systematically evaluat-
ing the use of AI guided LA posterior wall substrate 
modification aiming for electrical isolation of the 
posterior wall. Four major findings are reported 
in this study: First, AI guided PWI for substrate 
Figure 3. Box-plots depicting the mean values for ablation index (AI), catheter-tip to tissue contact force and maxi-
mum temperature rising for both groups. Values for the roof line are listed on the left side, values for the bottom 
lines are shown on the right. A. Ablation index roof line; B. Ablation index bottom line; C. Catether tip-to-tissue 
contact force roof line [g]; D. Catether tip-to-tissue contact force bottom line [g]; E. Maximum temperature roof line 
[°C]*; F. Maximum temperature bottom line [g]. The AI was significantly higher in the AI-group and the maximum 
temperature rise was significantly lower, respectively (for both p < 0.01). In addition, the contact force administered 
for the roof line was significantly higher in the AI-guided group. Of note, the variance in the AI-guided group was 
very small indicating a very good reproducibility of lesion application and formation using the AI; *As measured 
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modification in AF patients is safe and reproducibly 
effective. Second, performing AI-guided LA linear 
lesions across the LA roof and bottom in patients 
with PVI results in a high rate of first-pass PWI. 
Third, using target AI values results in a significant 
decrease of temperature exposure during lesion 
formation at the posterior wall. Fourth, AI guided 
application of the posterior box lesion set is as-
signed by improved lesion formation focussing on 
CF and AI.
Left atrial posterior wall isolation:  
Technically challenging
The STAR AF trial [1, 25] failed to demon-
strate a relevant benefit of LA lines and ablation 
of complex fractionated atrial electrograms beyond 
PVI in patients with PERS. However, catheter abla-
tion aiming for LA PWI was not part of the study. 
Approaches of PWI include box isolation, single 
ring isolation, and debulking ablation [9]. A recent 
meta-analysis from Thiyagarajah et al. [9] demon-
strated that acute LA PWI as a procedural endpoint 
was achieved in 78.5% with a pooled estimate of 
70.9% in 12 studies [26–37]. The authors reported 
pooled estimates for 12-months freedom from any 
arrhythmia recurrence of 65.3% and 61.9% for 
patients with PERS, respectively. In the present 
study acute procedural success was achieved in all 
patients and recurrence free survival during the 
follow-up period was 80% and 90%, respectively. 
In this context, it is well known that incomplete 
bidirectional conduction block has been associated 
with an increase in subsequent arrhythmia during 
follow-up [14, 15]. In the recent study, even re-
specting the criteria for contiguity and AI in group 
2, complete block across the roof in 90% of patients 
and in 85% at the bottom line after a single linear 
lesion set was achieved. The very high success rate 
of first-pass block of both LA lines in the current 
study can probably be explained by the specific 
anatomy of the LA roof with a thin wall thickness 
ranging from 3.5 to 6 mm and relatively smooth 
inferior parts of the posterior wall [38], which 
finally render the posterior wall quite suitably for 
a strategy aiming at transmurality and contiguity 
of RF lesions. Moreover, and as demonstrated in 
Figure 3A and B, AI-guided ablation lesions were 
created with a remarkably lower variance in target 
Table 2. Procedural data and their respective p-value.
Group 1 (CF) Group 2 (AI) P
Procedure duration [min] 98 ± 23 92 ± 9 0.10
Fluoroscopy time [min] 4.2 ± 1.6 4.1 ± 1.9 0.87
Ablation time [total] 2.7 ± 2.5 2.5 ± 1.6 0.67
Ablation time [min]:
Roof line 1.9 ±1.1 1.5 ± 0.8 0.14
Bottom line 3.5 ± 3.1 3.5 ± 1.6 0.95
Length [mm]:
Roof line 115 ± 70 90 ± 50 0.06
Bottom line 207 ± 98 210 ± 186 0.73
No of RF applications:
Roof line 4 ± 3 4 ± 1 0.92
Bottom line 10 ± 7 10 ± 5 0.84
Contact force [g]:
Roof line 32 ± 18 39 ± 17 0.01*
Bottom line 21 ± 16 22 ± 16 0.92
Ablation index:
Roof line 482 ± 108 549 ± 74 < 0.01*
Bottom line 442 ± 127 428 ± 99 < 0.01*
Maximal temperature:
Roof line 27 ± 1.4 25 ± 1.3 < 0.01*
Bottom line 27 ± 1.2 25 ± 1.7 < 0.01*
*Significant; AI — ablation index; CF — contact force; RF — radiofrequency
www.cardiologyjournal.org 7
Christian Sohns et al., Ablation index guided posterior wall isolation
values at the roof and bottom line as compared to 
CF-guided ablation alone (Fig. 3).
Left atrial posterior wall ablation: The narrow 
ridge between effectiveness and risk
Hypothesized herein, that AI-guided lesion 
formation at the LA posterior wall could be help-
ful in avoiding complications in these high-risk 
procedures. In their meta-analysis Thiyagarajah et 
al. [9] reported that 15 major complications were 
found across 1667 ablation procedures aiming for 
PWI. Pericardial effusion requiring drainage or 
cardiac tamponade were observed in 10 patients, 
cerebrovascular events in 3 patients, and atrio-
esophageal fistulas in 2 patients [9, 33]. There are 
multiple approaches to PWI with different strate-
gies of power delivery, RF application time, image 
integration, endpoints and in the context of tem-
perature monitoring for the esophagus [9]. In the 
present study, no major complication was observed 
using an AI of 400 for ablation at the posterior 
wall. In this context, Figure 3E and F emphasize 
that a significant lower maximum temperature rise 
was observed performing ablation guided by AI in 
line with improved lesion formation (Fig. 3E, F). 
In studies focusing on RF ablation in the canine 
heart, Nakagawa et al. [39, 40] found that the RF 
lesion depth was accurately (± 1 mm) described by 
a logarithmic function of CF, RF power and applica-
tion time. However, today AI-guided AF ablation 
does not take into account atrial wall thickness and 
individual distribution of fibrosis in the logarithmic 
function, although these factors may play an im-
portant role in the initialization and maintenance 
of PERS [41, 42]. Based on the current findings 
and those discussed above we would like to ad-
dress the need for personalized paths in catheter 
based PERS management in terms of efficacy and 
safety and therefore suggest a shift to the current 
AI approach to a substrate-based index taking into 
account the individual LA architecture as well as 
the amount and distribution of fibrosis.
The potential benefit of both continuous 
and optimized RF lesions
Recently, several studies reported beneficial 
effects of AI-guided ablation approaches for PVI 
with respect to periprocedural workflow, acute 
procedural success (first-pass PVI) and freedom 
from arrhythmia recurrence [18, 43–45]. Focusing 
on LA RF lesions, Taghji et al. [18] demonstrated 
that for durable PVI, the maximum interlesion 
distance should not exceed 6 mm and the minimal 
AI should be ≥ 400 at the posterior and ≥ 550 at the 
anterior aspects of the PVs. Beyond PVI, Santoro et 
al. [20] reported interesting data about the feasibil-
ity and safety of LA anterior line ablation using AI 
and interlesion distance measurement with shorter 
ablation time, shorter overall RF application time 
and a reduced number of RF applications to achieve 
anterior line bidirectional block. Another study by 
Wolf et al. [19] evaluated LA linear ablation using con-
tiguous and optimized RF lesions for linear ablation 
across the LA roof and the posterior mitral isthmus. 
The authors concluded, that their ablation approach 
resulted in a high rate of first-pass block at the roof but 
not at the mitral isthmus. The present data confirms 
the results from Wolf et al. [19] with respect to linear 
lesion sets across the LA roof and also emphasizes the 
beneficial effects of an AI-guided approach in terms 
of workflow improvement, transmural lesion forma-
tion and estimation of reproducible AI target values 
(Fig. 3). The same effect was observed for the bottom 
line leading to consecutive LA PWI (Fig. 3). Conse-
quently, this AI-guided approach resulted in PWI as 
a consequence of roof and inferior lines without the 
additional need of ablation inside the box. Based on 
these findings, we hypothesize that AI-guided linear 
ablation aiming for LA PWI respecting strict criteria 
of contiguity and indirect lesion assessment would 
also improve achievement of both acute and durable 
bidirectional block across linear lesion sets resulting 
in persistent PWI.
Limitations of the study
This is a single-center study with a limited 
number of patients. Although no safety-related is-
sues were observed, larger studies are necessary 
to validate the safety and efficacy of this protocol 
for LA posterior wall substrate modification. Pre-
vious ablation for PVI may have affected the atrial 
tissue at the posterior wall differently according to 
previous RF- or cryoballoon-guided PVI (Fig. 1). 
However, high density mapping was performed in all 
patients to visualize the area of bipolar low voltage 
on the posterior wall representing scarred or fi-
brotic tissue. Another limitation might be the lack of 
a direct luminal esophageal temperature monitoring 
during PWI in the present study. Luminal esophageal 
temperature is not performed in clinical routine 
during AF ablation at our center due its potential 
compound role in the context of lesion formation.
Conclusions
Ablation index-guided LA PWI for substrate 
modification in AF patients is safe and reproduc-
ibly effective. Furthermore, AI-guided applica-
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tion of the posterior box lesion set is featured by 
improved lesion formation with respect to CF, AI 
and temperature development. The present find-
ings suggest AI-guided ablation is safe, effective 
and transmural linear LA RF lesions across the 
posterior LA wall.
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